FENAC EC diclofenac sodium 25 mg enteric coated  tablet blister pack Australia - engleză - Department of Health (Therapeutic Goods Administration)

fenac ec diclofenac sodium 25 mg enteric coated tablet blister pack

alphapharm pty ltd - diclofenac sodium, quantity: 25 mg - tablet, enteric coated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; sodium starch glycollate type a; magnesium stearate; iron oxide yellow; purified talc; peg-40 hydrogenated castor oil; methacrylic acid - ethyl acrylate copolymer (1:1); lactose monohydrate; maize starch; triethyl citrate; povidone; hypromellose; titanium dioxide - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. relief of acute or chronic pain states in which there is an,inflammatory component. symptomatic treatment of primary dysmenorrhoea.

FENAC EC diclofenac sodium 50 mg enteric coated tablet blister pack Australia - engleză - Department of Health (Therapeutic Goods Administration)

fenac ec diclofenac sodium 50 mg enteric coated tablet blister pack

alphapharm pty ltd - diclofenac sodium, quantity: 50 mg - tablet, enteric coated - excipient ingredients: peg-40 hydrogenated castor oil; magnesium stearate; purified talc; povidone; sodium starch glycollate type a; hypromellose; titanium dioxide; maize starch; triethyl citrate; iron oxide red; iron oxide yellow; lactose monohydrate; microcrystalline cellulose; colloidal anhydrous silica; methacrylic acid - ethyl acrylate copolymer (1:1) - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. relief of acute or chronic pain states in which there is an,inflammatory component. symptomatic treatment of primary dysmenorrhoea.

DICLOFENAC SODIUM VIATRIS diclofenac sodium 25 mg enteric coated tablet blister pack Australia - engleză - Department of Health (Therapeutic Goods Administration)

diclofenac sodium viatris diclofenac sodium 25 mg enteric coated tablet blister pack

sandoz pty ltd - diclofenac sodium, quantity: 25 mg - tablet, enteric coated - excipient ingredients: triethyl citrate; purified talc; sodium starch glycollate; magnesium stearate; maize starch; iron oxide yellow; calcium hydrogen phosphate dihydrate; methacrylic acid copolymer; microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide; lactose monohydrate - inflammatory and degenerative forms of rheumatism; rheumatoid arthritis; osteoarthritis. relief of acute or chronic pain states in which there is an inflammatory component. symptomatic treatment of primary dysmenorrhoea.

DICLOFENAC SODIUM VIATRIS diclofenac sodium 50 mg enteric coated tablet blister pack Australia - engleză - Department of Health (Therapeutic Goods Administration)

diclofenac sodium viatris diclofenac sodium 50 mg enteric coated tablet blister pack

sandoz pty ltd - diclofenac sodium, quantity: 50 mg - tablet, enteric coated - excipient ingredients: maize starch; methacrylic acid copolymer; colloidal anhydrous silica; magnesium stearate; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; purified talc; triethyl citrate; iron oxide yellow; titanium dioxide; lactose monohydrate; sodium starch glycollate - inflammatory and degenerative forms of rheumatism; rheumatoid arthritis; osteoarthritis. relief of acute or chronic pain states in which there is an inflammatory component. symptomatic treatment of primary dysmenorrhoea.

DICLOFENAC Actavis diclofenac sodium 50mg enteric-coated tablet blister pack Australia - engleză - Department of Health (Therapeutic Goods Administration)

diclofenac actavis diclofenac sodium 50mg enteric-coated tablet blister pack

medis pharma pty ltd - diclofenac sodium, quantity: 50 mg - tablet, enteric coated - excipient ingredients: lactose monohydrate; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; maize starch; sodium starch glycollate; magnesium stearate; colloidal anhydrous silica; methacrylic acid copolymer; triethyl citrate; purified talc; titanium dioxide; iron oxide yellow - inflammatory and degenerative forms of rheumatism; rheumatoid arthritis; osteoarthritis. relief of acute or chronic pain states in which there is an inflammatory component. symptomatic treatment of primary dysmenorrhoea.

DICLOFENAC Actavis diclofenac sodium 25mg enteric-coated tablet blister pack Australia - engleză - Department of Health (Therapeutic Goods Administration)

diclofenac actavis diclofenac sodium 25mg enteric-coated tablet blister pack

medis pharma pty ltd - diclofenac sodium, quantity: 25 mg - tablet, enteric coated - excipient ingredients: lactose monohydrate; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; maize starch; sodium starch glycollate; magnesium stearate; colloidal anhydrous silica; methacrylic acid copolymer; triethyl citrate; purified talc; titanium dioxide; iron oxide yellow - inflammatory and degenerative forms of rheumatism; rheumatoid arthritis; osteoarthritis. relief of acute or chronic pain states in which there is an inflammatory component. symptomatic treatment of primary dysmenorrhoea.

DICLOFENAC-50 TABLET (ENTERIC-COATED) Canada - engleză - Health Canada

diclofenac-50 tablet (enteric-coated)

pro doc limitee - diclofenac sodium - tablet (enteric-coated) - 50mg - diclofenac sodium 50mg - other nonsteroidal antiimflammatory agents

Diclofenac Sandoz Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

diclofenac sandoz

sandoz new zealand limited - diclofenac sodium 25mg;   - enteric coated tablet - 25 mg - active: diclofenac sodium 25mg   excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide iron oxide yellow lactose monohydrate magnesium stearate maize starch methacrylic acid copolymer microcrystalline cellulose purified talc sodium starch glycolate titanium dioxide triethyl citrate - treatment of: inflammatory and degenerative forms of rheumatism - rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism; acute attacks of gout; post-traumatic and post-operative pain, inflammation, and swelling, e.g. following dental or orthopaedic surgery; painful and/or inflammatory conditions in gynaecology, e.g. primary dysmenorrhoea or adnexitis; as an adjuvant in severe painful inflammatory infections of the ear, nose, or throat, e.g. pharyngotonsillitis, otitis. in keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. fever alone is not an indication.